- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07762963
Turkish Validation of the Core Life Activities Scale (CORE-TR)
Turkish Version of the Core Life Activities Scale: Validity and Reliability Study
Studieoversikt
Status
Forhold
Detaljert beskrivelse
his observational methodological study will evaluate the validity and reliability of the Turkish version of the Core Life Activities Scale (CORE). The study will include approximately 300 Turkish-speaking adults aged 18 years and older from different age groups and socioeconomic backgrounds.
The CORE is a five-item self-report measure designed to assess five core areas of daily life: eating habits, sleep, physical activity, learning new things, and social relationships. Each item is rated on a five-point Likert scale ranging from 1 (never) to 5 (always).
After providing informed consent, participants will complete a demographic information form, the Turkish version of the CORE, the 12-Item Short Form Health Survey (SF-12), and the World Health Organization Quality of Life-BREF (WHOQOL-BREF). The SF-12 and WHOQOL-BREF will be used to examine the validity of the Turkish CORE. The CORE will be administered again one week later to assess test-retest reliability.
Psychometric analyses will be performed to evaluate the reliability and validity of the Turkish version of the CORE. Internal consistency, test-retest reliability, and construct-related validity will be examined. Data collection is planned between August 20, 2026 and September 30, 2026.
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Uğur Sözlü, PhD
- Telefonnummer: 05368921936
- E-post: ugur.sozlu@gop.edu.tr
Studiesteder
-
-
-
Tokat Province, Tyrkia (Türkiye), 60150
- Tokat Gaziosmanpasa University, Faculty of Health Sciences
-
Ta kontakt med:
- Uğur Sözlü
- Telefonnummer: 05368921936
- E-post: ugur.sozlu@gop.edu.tr
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
Adults aged 18 years or older. Ability to read and understand Turkish fluently. No cognitive or physical impairment that would prevent completion of the questionnaires.
Willingness to participate voluntarily and provide informed consent.
Exclusion Criteria:
Diagnosis of a severe psychiatric or neurological disorder such as schizophrenia, bipolar disorder, or dementia.
Presence of a terminal or severe medical condition that substantially affects activities of daily living, such as advanced-stage cancer or severe cardiovascular disease.
Language barriers that prevent adequate understanding of the questionnaires. Providing inconsistent, intentionally inaccurate, or implausibly rapid questionnaire responses.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Turkish-Speaking Adults
Approximately 300 Turkish-speaking adults aged 18 years and older will be included in this observational validation study.
Participants will complete the Turkish version of the Core Life Activities Scale (CORE), the SF-12, and the WHOQOL-BREF.
The CORE will be administered again one week later to assess test-retest reliability.
No intervention will be administered.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Internal Consistency of the Turkish Core Life Activities Scale
Tidsramme: Baseline
|
Internal consistency of the Turkish version of the Core Life Activities Scale (CORE) will be evaluated using Cronbach's alpha coefficient.
The CORE consists of five items assessing eating, sleeping, physical activity, learning new things, and social relationships, with each item rated on a 5-point Likert scale from 1 (never) to 5 (always).
|
Baseline
|
|
Test-Retest Reliability of the Turkish Core Life Activities Scale
Tidsramme: Baseline and 1 week
|
Test-retest reliability of the Turkish version of the CORE will be evaluated by comparing CORE scores obtained at the initial assessment with scores obtained one week later.
The association between the two assessments will be examined to determine the temporal stability of the scale.
|
Baseline and 1 week
|
|
Construct Validity of the Turkish Core Life Activities Scale
Tidsramme: Baseline
|
Construct validity of the Turkish version of the CORE will be evaluated by examining its relationships with health-related quality of life measures assessed using the 12-Item Short Form Health Survey (SF-12) and the World Health Organization Quality of Life-BREF (WHOQOL-BREF).
|
Baseline
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Factor Structure of the Turkish Core Life Activities Scale
Tidsramme: Baseline
|
The factor structure of the Turkish version of the CORE will be examined using factor analysis to evaluate its underlying dimensional structure.
|
Baseline
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Uğur Sözlü, PhD, Tokat Gaziosmanpaşa Üniversitesi
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- E-13232362-100-582766
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .